Neurometrix Stock In The News

NURO Stock  USD 4.25  0.10  2.41%   
Our overall analysis of NeuroMetrix's news coverage and content from conventional and social sources shows investors' bearish mood towards NeuroMetrix. The specific impact of NeuroMetrix news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of NeuroMetrix's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using NeuroMetrix headlines in addition to utilizing other, more conventional financial analysis modules. Check out NeuroMetrix Backtesting and NeuroMetrix Hype Analysis.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

NeuroMetrix Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
NeuroMetrix Announces One-for-Eight Reverse Stock Split
https://www.globenewswire.com/news-release/2023/11/20/2783281/0/en/NeuroMetrix-Announces-One-for-Eight-Reverse-Stock-Split.html
 Bullish
Macroaxis News: globenewswire.com
Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now
https://www.globenewswire.com/news-release/2023/11/01/2770956/0/en/Presenting-on-the-Emerging-Growth-Conference-64-Day-2-on-November-2-Register-Now.html
 Bullish
Macroaxis News: globenewswire.com
Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now
https://www.globenewswire.com/news-release/2023/10/31/2769992/0/en/Presenting-on-the-Emerging-Growth-Conference-64-Day-1-on-November-1-Register-Now.html
 Bullish
Macroaxis News: globenewswire.com
NeuroMetrix to Present at the Emerging Growth Conference on November 1, 2023
https://www.globenewswire.com/news-release/2023/10/30/2769278/0/en/NeuroMetrix-to-Present-at-the-Emerging-Growth-Conference-on-November-1-2023.html
 Bullish
Macroaxis News: globenewswire.com
NeuroMetrix Reports Q3 2023 Business Highlights
https://www.globenewswire.com/news-release/2023/10/26/2767339/0/en/NeuroMetrix-Reports-Q3-2023-Business-Highlights.html
 Neutral
Macroaxis News: globenewswire.com
NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference Call
https://www.globenewswire.com/news-release/2023/10/23/2764934/0/en/NeuroMetrix-Inc-Announces-Date-for-Third-Quarter-2023-Business-and-Financial-Highlights-Conference-Call.html
 Neutral
Macroaxis News: globenewswire.com
Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now
https://www.globenewswire.com/news-release/2023/10/04/2754417/0/en/Presenting-on-the-Emerging-Growth-Conference-63-Day-2-on-October-5-Register-Now.html
 Bullish
Macroaxis News: globenewswire.com
Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now
https://www.globenewswire.com/news-release/2023/10/03/2753473/0/en/Presenting-on-the-Emerging-Growth-Conference-63-Day-1-on-October-4-Register-Now.html
 Bullish
Macroaxis News: globenewswire.com
NeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with Fibromyalgia
https://www.globenewswire.com/news-release/2023/10/02/2752773/0/en/NeuroMetrix-and-the-National-Fibromyalgia-Association-to-Collaborate-to-Improve-the-Quality-of-Life-for-People-Living-with-Fibromyalgia.html
 Bullish
Macroaxis News: globenewswire.com
NeuroMetrix to Present at the Emerging Growth Conference on October 4, 2023
https://www.globenewswire.com/news-release/2023/09/28/2751492/0/en/NeuroMetrix-to-Present-at-the-Emerging-Growth-Conference-on-October-4-2023.html
 Bullish

NeuroMetrix Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide NeuroMetrix and other traded companies coverage with news coverage. We help investors stay connected with NeuroMetrix headlines for the 23rd of November to make an informed investment decision based on correlating the impacts of news items on NeuroMetrix Stock performance. Please note that trading solely based on the NeuroMetrix hype is not for everyone as timely availability and quick action are needed to avoid losses.
NeuroMetrix's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help NeuroMetrix investors visualize upcoming and past events in order to time the market based on NeuroMetrix noise-free hype analysis.
NeuroMetrix stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the NeuroMetrix earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about NeuroMetrix that are available to investors today. That information is available publicly through NeuroMetrix media outlets and privately through word of mouth or via NeuroMetrix internal channels. However, regardless of the origin, that massive amount of NeuroMetrix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NeuroMetrix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NeuroMetrix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NeuroMetrix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NeuroMetrix alpha.

NeuroMetrix Largest EPS Surprises

Earnings surprises can significantly impact NeuroMetrix's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-01-24
2018-12-31-1.4-2.01-0.6143 
2018-04-19
2018-03-31-0.580.080.66113 
2018-07-19
2018-06-30-0.350.40.75214 
2021-10-21
2021-09-30-1.8-0.960.8446 
2020-01-27
2019-12-31-1.8-3.0-1.266 
2021-04-22
2021-03-31-1.8-0.161.6491 
View All Earnings Estimates

NeuroMetrix Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to NeuroMetrix Stock. Current markets are strongly bullish. About 89% of major world exchanges and indexes are currently up. See today's market update for more information.
Macroaxis News
21st of November 2024
Disposition of 498 shares by Thomas Higgins of NeuroMetrix at 3.03 subject to Rule 16b-3
at MacroaxisInsider 
news
15th of November 2024
NeuroMetrix Earns Sell Rating from Analysts at StockNews.com
at thelincolnianonline.com 
Yahoo News
6th of November 2024
NeuroMetrix Third Quarter 2024 Earnings US0.75 loss per share
at finance.yahoo.com 
Macroaxis News: globenewswire.com
5th of November 2024
NeuroMetrix Reports Q3 2024 Business Highlights
at globenewswire.com 
Macroaxis News
1st of October 2024
Disposition of 625 shares by Gozani Shai of NeuroMetrix at 4.18 subject to Rule 16b-3
at MacroaxisInsider 
Usa forbes News
11th of September 2024
Nuro Pivots From Delivery Bots To Licensing Automated Driving Software
at forbes.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NeuroMetrix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NeuroMetrix's short interest history, or implied volatility extrapolated from NeuroMetrix options trading.
When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:
Check out NeuroMetrix Backtesting and NeuroMetrix Hype Analysis.
To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.62)
Revenue Per Share
2.157
Quarterly Revenue Growth
(0.51)
Return On Assets
(0.28)
Return On Equity
(0.43)
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.